Results 191 to 200 of about 53,280 (246)

A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis. [PDF]

Cureus
Unnikrishnan P, Vudayana K, Chintada D, Khatija Begum M, Chalamalasetty SS, Gullipalli P.   +5 more
europepmc   +1 more source

Clinical Efficacy of Tofacitinib in Treating Granulomatous Reaction After Mesotherapy: A Case Series Analysis. [PDF]

J Cosmet Dermatol
Shu C, Zhang T, Liu JW, Zhu CY, Fang RY, Sun QN, Li N, Li F.   +7 more
europepmc   +1 more source

JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. [PDF]

JGH Open
Qtaishat FA, AlKayyat A, Yasin JA, A Tamimi MA, Tarawneh J, AlDaher L, Abdallah S, Alghaniem MMA, Abunamoos A, Musa A, Ateiwi YA, Taha Y, Tamimi TA.   +12 more
europepmc   +1 more source

Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis. [PDF]

Int J Clin Pharmacol Ther
Tsuchiwata S, Suzuki A, Wang Q, Kanik K, Fallon L, Menon S.   +5 more
europepmc   +1 more source

Tofacitinib repairs inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed RA macrophages. [PDF]

Cell Mol Immunol
Satoeya N, Zack SR, Zoubi OA, Umar S, Burgos A, Abdulrab S, Zanotti B, Volin MV, Karam JA, Xia Y, Umali DC, Arami S, Al-Awqati M, Chang HT, O'Neill LAJ, Schett G, Sweiss N, Shahrara S.   +17 more
europepmc   +1 more source

NLRP12 Deficiency Enhances Tofacitinib Efficacy in DSS Colitis Via STAT1-M1 Polarization. [PDF]

Inflammation
Yi Y, Wei Q, Chen S, Li L, Dekyi W, Jia H, Shu X, Zhao Q, Chang Y.   +8 more
europepmc   +1 more source

Tofacitinib-Induced Weight Gain in Context: comment on the article by Wollenhaupt et al. [PDF]

ACR Open Rheumatol
Palmowski A, Buttgereit F, Simon D, Kleyer A, Drzeniek NM.   +4 more
europepmc   +1 more source

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

, 2020
Bathon, J., Breedveld, F., Burmester, G., Bykerk, V., Crofford, L., Cronstein, B., Dougados, M., Furst, D., Kalden, J., Mariette, X., Mease, P., Melchers, F., Rosenbaum, J., Sieper, J., Smolen, J., Weinblatt, M., Winthrop, K.   +16 more
core   +1 more source

Comment on published article "A Real-World Study of Tofacitinib in Indian Patients with Refractory Moderate-to-Severe Atopic Dermatitis, its Economic Considerations and Immunological Rationale". [PDF]

Indian Dermatol Online J
Gupta A, Neema S.
europepmc   +1 more source

Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team. [PDF]

Intest Res
Hong SM, Kim DH, Bae JH, Shin SY, Song EM, Kim JE, Yang YJ, Yoon J, Kang SB, Kim ES, Kim SE, Kim SJ, Lee J, Na SY, Park SJ, Park SH, Choi M, Kim MH, Moon W, Jung SA.   +19 more
europepmc   +1 more source